Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)
Top Cited Papers
- 1 July 2000
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 356 (9227) , 366-372
- https://doi.org/10.1016/s0140-6736(00)02527-7
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Major Cardiovascular Events in Hypertensive Patients Randomized to Doxazosin vs Chlorthalidone: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2000
- Hypertension and Antihypertensive Therapy as Risk Factors for Type 2 Diabetes MellitusNew England Journal of Medicine, 2000
- 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of HypertensionClinical and Experimental Hypertension, 1999
- An Overview of 37 Randomised Trials of Blood Pressure Lowering Agents Among 270,000 IndividualsClinical and Experimental Hypertension, 1999
- Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertensionJournal Of Hypertension, 1998
- Changes in estimated coronary risk in the 1980s: data from 38 populations in the WHO MONICA ProjectAnnals of Medicine, 1998
- Shanghai trial of nifedipine in the elderlyJournal Of Hypertension, 1996
- Diuretic Therapy for Hypertension and the Risk of Primary Cardiac ArrestNew England Journal of Medicine, 1994
- Blood pressure, stroke, and coronary heart disease: Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological contextPublished by Elsevier ,1990
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976